Abstract
Front end innovation (FEI) represents the first building blocks of product development, but is often regarded as a weak link in innovation literature. Various theorists emphasize that a firm’s innovation can benefit substantially by improving the front end of innovation process (Reinertsen, Res Technol Manag 42:23–31, 1999; Stevens and Burly, Res Technol Manag 46(2):16–25, 2003; Verworn et al., R&D Manag 38(1):1–19, 2008) and that innovation strategies play a central role in optimization of innovation (Clark and Wheelwright, Leading product development, Free Press, New York, 1995; Cottam et al., Eur J Innov Manag 4:88–94, 2001; Morgan and Berthon, J Manag Stud 45(8):1329–1353, 2008). Innovation strategies are suggested in literature (e.g. Page, J Prod Innov Manag 10:273–287, 1993; Oke, J Change Manag 2(3):272–281, 2002; Adams et al., Int J Manag Rev 8(1):21–47, 2006; Igartua et al., Res Technol Manag May–June:41–52, 2010) as a facilitator of innovation and may therefore also be targeted at FEI support. The pharmaceutical industry has experienced a worldwide decline in the number of applications for new molecular entities to regulatory agencies since 1997. Therefore high pressures are put on pharmaceutical research and FEI to produce more valid candidates and faster for drug development. This paper explores how pharmaceutical FEI can be actively supported through the development and implementation of an innovation strategy. The empirical field and applied methodology is an action oriented longitudinal case study of a Danish pharmaceutical company. The findings and key learnings from the study are presented as propositions of how innovation strategies can be applied to actively facilitate FEI and with measurable results.
Similar content being viewed by others
Notes
Action research and the action oriented approach applied in this study will be referred to as AR throughout the article.
The AR researcher resembles the author of this paper.
References
Adams R, Bessant J, Phelps R (2006) Innovation management measurement: a review. Int J Manag Rev 8(1):21–47
Alexander K, Kaya S, Nelson M (2003) Learning partnerships in facilities management: a new action learning approach. In: Proceedings of the building education and research (BEAR) conference, Salford
Altrichter H, Kemmis S, McTaggart R, Zuber-Skerritt O (2002) The concept of action research. Learn Organ 9(3):125–131
Alves J, Marques MJ, Saur I, Marques P (2005) Building creative ideas for successful new product development. In: ECCI 9—the 9th European conference on creativity and innovation: ‘Transformations’, Lodz, Poland
Amabile TM (1998) How to kill creativity. Harvard Bus Rev 76(5):76–87
Amabile TM et al (1996) Assessing the work environment for creativity. Acad Manag J 39(5):1154–1185
Atuahene-Gima K (1995) An exploratory analysis of the impact of market orientation on new product performance: a contingency approach. J Prod Innov Manag 12(4):275–293
Backman M, Börjesson S, Setterberg S (2007) Working with concepts in the fuzzy front end: exploring the context for innovation for different types of concepts at Volvo Cars. R&D Manag 37(1):17–28
Boeddrich HJ (2004) Ideas in the workplace: a new approach towards organizing the fuzzy front end of the innovation process. Creat Innov Manag 13(4):274–285
Booz, Allen, and Hamilton (1982) New product management for the 1980s. Booz, Allen, and Hamilton, New York
Brennan A, Dooley L (2005) Networked creativity: a structured management framework for stimulating innovation. Technovation 25:1388–1399
Clark K, Wheelwright CS (1995) Leading product development. Free Press, New York
Coghlan D, Brannick T (2001) Doing action research in your own organisation. Sage Publications, London
Cooper RG (1988) Predevelopment activities determine new product success. Ind Mark Manag 17(3):237–247
Cooper RG (1999) From experience: the invisible success factors in product innovation. J Prod Innov Manag 16:115–133
Cooper RG, Kleinschmidt EJ (1994) Screening new products for potential winners. IEEE Trans Eng Manag 22(4):24–30
Cooper RG, Kleinschmidt EL (1996) Winning businesses in product development: the critical success factors. Res Technol Manag July–August:18–29
Cottam A, Ensor J, Band C (2001) A benchmark study of strategic commitment to innovation. Eur J Innov Manag 4:88–94
Ding M, Eliashberg J (2002) Structuring the new product development pipeline. Manag Sci 48(3):343–363
Duyck J (2003) Attrition and translation. Science 302(Oct 24):603–605. ISSN 0036-8075
Dwyer L, Mellor R (1991) Organisational environment, new product process activities, and project outcomes. J Prod Innov Manag 8(1):39–48
Dyck WV, Allen PM (2006) Pharmaceutical discovery as a complex system of decisions: the case of front-loaded experimentation. E:CO 8(3):40–56
Englund RL, Graham RJ (1999) From experience: linking projects to strategy. J Prod Innov Manag 16(1):52–64
Gobeli DH, Brown DJ (1987) Analyzing product innovations. Res Manag 30(4):25–30
Greenwood D, Levin M (1998) Introduction to action research. Sage Publications, Thousand Oaks
Hart E (1996) Action research as a professionalising strategy: issues and dilemmas. J Adv Nurs 23:454–461
He ZL, Wong PK (2004) Exploration vs. exploitation: an empirical test of the ambidexterity hypothesis. Organ Sci 15(4):481–494
Herson J (2005) Innovation in pharmaceuticals: speeding up the development of new cures. Futurist Jan–Feb:25–29
Hüsig S, Kohn S (2003) Factors influencing the front end of innovation process: a comprehensive review of selected empirical NPD and explorative FFE studies. Proceedings of the 10th IPDMC
Igartua JI, Garrigós JA, Hervas-Oliver JL (2010) How innovation management techniques support an open innovation strategy. Res Technol Manag May–June:41–52
Johne AF, Snelson PA (1988) Success factors in product innovation: a selective review of the literature. J Prod Innov Manag 5:114–128
Khurana A, Rosenthal SR (1998) Towards holistic ‘Front Ends’ in new product development. J Prod Innov Manag 15:57–74
Kim J, Wilemon D (2002) Focusing the fuzzy front end in new product development. R&D Manag 32(4):269–279
Kleinschmidt EJ, Cooper RG (1995) The relative importance of new product success determinants: perception versus reality. R&D Manag 25(3):281–297
Koch T, Harrington A (1998) Reconceptualizing rigour: the case for reexivity. J Adv Nurs 28:882–890
Koen PA et al (2001) Providing clarity and a common language to the fuzzy front end. Res Technol Manag 44:46–55
Kvale S, Brinkmann S (2008) InterViews—learning the craft of qualitative research interviewing, 2nd edn. Sage Publications, Thousand Oaks
Lester DH (1998) Critical success factors for new product development. Res Technol Manag 41(1):36–43
Lynn GS, Akgun AE (1998) Innovation strategies under uncertainty: a contingency approach for new product development. Eng Manag J 10(30):11–17
Maaløe E (2002) Case-studier af og om mennesker i organisationer, 2nd edn. Akademisk Forlag, København
Martins EC, Terblanche F (2003) Building organisational culture that stimulates creativity and innovation. Eur J Innov Manag 6(1):64–74
Morgan RE, Berthon P (2008) Market orientation, generative learning, innovation strategy and business performance inter-relationships in bioscience firms. J Manag Stud 45(8):1329–1353
Moss QZ, Alho J, Alexander K (2007) Performance measurement action research. J Facil Manag 5(4):290–300
Nielsen KA, Svensson L (eds) (2006) Action and interactive research—beyond practice and theory. Shaker Publishing, Maastricht
Nobelius D, Trygg L (2002) Stop chasing the front end process—management of the early phases in product development projects. Int J Proj Manag 20:331–340
Oke A (2002) Making it happen: how to improve innovative capability in a service company. J Change Manag 2(3):272–281
Pacl H, Festel G, Wess G (2004) The future of Pharma R&D. Festel Capital, Huenenberg
Page AL (1993) Assessing new product development practices and performance: establishing crucial norms. J Prod Innov Manag 10:273–287
Perttula MK (2004) Implications on cultural and formal processes of the front-end of new product development. In: Proceedings of 2nd world conference on production and operations management, Cancun, Mexico, 30 April–3 May
Price Waterhouse Coopers (PWC) (2007) Pharma futures—prescription for long-term value. SustainAbility Ltd, ISBN 978-1-903168-19-6, pp 1–40
Reason P (2001) Learning and change through action research. In: Henry J (ed) Creative management, 2nd edn. Sage Publications, London, pp 182–194
Reid SE, Brentani U (2004) The fuzzy front end of new product development for discontinuous innovations: a theoretical model. J Prod Innov Manag 21:170–184
Reinertsen DG (1999) Taking the fuzziness out of the fuzzy front end. Res Technol Manag 42:25–31
Rice MP, Kelley D, Peters L, O’Connor GC (2001) Radical innovation: triggering initiation of opportunity recognition and evaluation. R&D Manag 31(4):409–420
Rothwell R (1992) Successful industrial innovation: critical success factors for the 1990 s. R&D Manag 3:221–239
Schmid EF, Smith DA (2005) Managing innovation in the pharmaceutical industry. J Commer Biotechnol 12(1):50–57
Shenhar AJ, Tishler A, Dvir D et al (2002) Refining the search for project success factors: a multivariate, typological approach. R&D Manag 32(2):111–126
Stevens GA, Burly J (2003) Piloting the rocket of radical innovation. Res Technol Manag 46(2):16–25
Tatikonda MV, Rosenthal SR (2000) Successful execution of product development projects: balancing firmness and flexibility in the innovation process. J Oper Manag 18:401–425
Verganti R (1999) Planned flexibility: linking anticipation and reaction in product development projects. J Prod Innov Manag 16:363–376
Verworn B, Herstatt C, Nagahira A (2008) The fuzzy front end of Japanese new product development projects: impact on success and differences between incremental and radical projects. R&D Manag 38(1):1–19
Williams MA, Kochbar AK, Tennant C (2007) An object-oriented reference model of the fuzzy front end of the new product introduction process. Int J Adv Manuf Technol 34(7–8):826–841
Winter R (2002) Truth of fiction: problems of validity and authenticity in narratives of action research. Educ Action Res 10(1):143–154
Yin RK (2003) Case study research: design and methods, 3rd edn. Sage Publishing, Thousand Oaks, CA
Zhang Q, Doll WJ (2001) The fuzzy front end and success of new product development: a causal model. Eur J Innov Manag 4(2):95–112
Zirger BJ (1997) The influence of development experience and product innovativeness on product outcome. Technol Anal Strateg Manag 9(3):287–297
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aagaard, A. The Contribution of Innovation Strategy Development and Implementation in Active Facilitation of Pharmaceutical Front End Innovation. Syst Pract Action Res 25, 457–477 (2012). https://doi.org/10.1007/s11213-012-9234-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11213-012-9234-z